Latest News and Press Releases
Want to stay updated on the latest news?
-
PHILADELPHIA, Nov. 25, 2025 (GLOBE NEWSWIRE) -- enCore Energy Corp. (NASDAQ: EU): Grabar Law Office is investigating claims on behalf of shareholders of enCore Energy Corp. (NASDAQ: EU). The...
-
PHILADELPHIA, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Fortrea Holdings, Inc. (NASDAQ: FTRE): Grabar Law Office is investigating claims on behalf of shareholders of Fortrea Holdings, Inc. (NASDAQ:...
-
PHILADELPHIA, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Fortrea Holdings, Inc. (NASDAQ: FTRE): Grabar Law Office is investigating claims on behalf of shareholders of Fortrea Holdings, Inc. (NASDAQ:...
-
HOUSTON, Nov. 20, 2025 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), announced today that it has signed...
-
PHILADELPHIA, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Avantor, Inc. (NYSE: AVTR): Grabar Law Office is investigating claims on behalf of shareholders of Avantor, Inc. (NYSE: AVTR). The investigation...
-
PHILADELPHIA, Nov. 09, 2025 (GLOBE NEWSWIRE) -- Avantor, Inc. (NYSE: AVTR): Grabar Law Office is investigating claims on behalf of shareholders of Avantor, Inc. (NYSE: AVTR). The investigation...
-
PHILADELPHIA, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) - Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...
-
PHILADELPHIA, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Avantor, Inc. (NYSE: AVTR): Grabar Law Office is investigating claims on behalf of shareholders of Avantor, Inc. (NYSE: AVTR). The investigation...
-
PHILADELPHIA, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) – Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...
-
PHILADELPHIA, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Five Below, Inc. (NASDAQ: FIVE) – Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of shareholders of...